Three major foreign capitals | Maintain the target price of TSMC

TSMC held a major information briefing yesterday, reaffirming that the virus attack on the machine had less than 2% of the revenue in the third quarter, and the annual revenue remained unchanged at the high single digit percentage. The domestic and foreign legal entities pointed out that TSMC is Without other negatives and doubts, today's opening market is expected to return to the fundamentals.

In response to the virus attack on TSMC, major foreign investors such as Morgan Stanley, Credit Suisse and CLSA issued a report for the first time, unanimously saying that the overall impact of the incident on TSMC's revenue this quarter is within reasonable limits and will not change TSMC. Leading position in advanced processes, maintaining existing ratings and target prices.

CLSA specifically pointed out that TSMC's priority strategy for handling this poisoning is to preserve advanced process orders such as 7 nm, 12 nm and 16 nm, including the A12 processor OEM for the new iPhone, followed by 40 nm. Within the mature process, the latter shipment may be deferred, Lyon is estimated to be August, and advanced processes are not affected.

Lyon is currently giving foreign investment to TSMC's highest target price. Based on TSMC's advanced process, it continues to lead, reiterating its target price of 300 yuan, and stressing that short-term correction is a buying point.

Chu Nansheng, chairman of Yongnan Investment Co., Ltd., said that due to the small impact of the poisoning incident, TSMC's share price only fell slightly yesterday, and foreign capital sold more than 4,801 sheets. Today's opening is expected to return to the fundamentals.

Chu Xiangsheng said that the legal person circle watched TSMC's 7-nanometer process, which is 'only this one, no semicolon', so it maintains a positive outlook.